Pfizer's AI Transformation: A Model for the Pharmaceutical Industry

Pfizer is widely recognized as one of the pharmaceutical industry's leaders in Artificial Intelligence adoption. By integrating AI across drug discovery, clinical trials, manufacturing, commercialization, and patient safety, Pfizer has created a connected ecosystem that accelerates innovation, improves efficiency, and enhances decision-making.

From AI-assisted development of PAXLOVID® to advanced clinical trial analytics and generative AI platforms such as "Charlie," Pfizer demonstrates how artificial intelligence can transform the entire pharmaceutical value chain.

At SXPEL Europe LDA, we analyze industry-leading AI strategies such as Pfizer's to help healthcare, biotechnology, and life sciences organizations develop their own AI transformation roadmaps and unlock sustainable competitive advantages in a rapidly evolving market.